Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants*

Many immunostimulants act as vaccine adjuvants via activation of the innate immune system, although in many cases it is unclear which specific molecules contribute to the stimulatory activity. QS-21 is a defined, highly purified, and soluble saponin adjuvant currently used in licensed and exploratory vaccines, including vaccines against malaria, cancer, and HIV-1. However, little is known about the mechanisms of cellular activation induced by QS-21. We observed QS-21 to elicit caspase-1-dependent IL-1β and IL-18 release in antigen-presenting cells such as macrophages and dendritic cells when co-stimulated with the TLR4-agonist adjuvant monophosphoryl lipid A. Furthermore, our data suggest that the ASC-NLRP3 inflammasome is responsible for QS-21-induced IL-1β/IL-18 release. At higher concentrations, QS-21 induced macrophage and dendritic cell death in a caspase-1-, ASC-, and NLRP3-independent manner, whereas the presence of cholesterol rescued cell viability. A nanoparticulate adjuvant that contains QS-21 as part of a heterogeneous mixture of saponins also induced IL-1β in an NLRP3-dependent manner. Interestingly, despite the role NLRP3 plays for cellular activation in vitro, NLRP3-deficient mice immunized with HIV-1 gp120 and QS-21 showed significantly higher levels of Th1 and Th2 antigen-specific T cell responses and increased IgG1 and IgG2c compared with wild type controls. Thus, we have identified QS-21 as a nonparticulate single molecular saponin that activates the NLRP3 inflammasome, but this signaling pathway may contribute to decreased antigen-specific responses in vivo.

• Publication year

  2015

• Venue

  Journal of Biological Chemistry

• Publication date

  2015-11-10

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1074/jbc.M115.683011PMID 26555265PMCID PMC4714196
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of liposomal cholesterol and monophosphoryl lipid A by QS-21 saponin and Limulus polyphemus amebocyte lysate.

  2015cited by this paper
• Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

  2015cited by this paper
• Enhancement of Adaptive Immunity by the Human Vaccine Adjuvant AS01 Depends on Activated Dendritic Cells

  2014cited by this paper
• Inflammasome-Dependent and -Independent IL-18 Production Mediates Immunity to the ISCOMATRIX Adjuvant

  2014cited by this paper
• Contribution of TLR4 and MyD88 for adjuvant monophosphoryl lipid A (MPLA) activity in a DNA prime-protein boost HIV-1 vaccine.

  2014cited by this paper
• Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death

  2014cited by this paper
• Activation of the NLRP3 inflammasome is not a feature of all particulate vaccine adjuvants

  2014cited by this paper
• Development of a minimal saponin vaccine adjuvant based on QS-21

  2014influential reference
• Mechanisms and functions of inflammasomes.

  2014cited by this paper
• Immunomodulatory properties of the vaccine adjuvant alum.

  2014cited by this paper
• Reduced MyD88 dependency of ISCOMATRIX™ adjuvant in a DNA prime-protein boost HIV vaccine

  2014cited by this paper
• Matrix-M™ adjuvant: enhancing immune responses by ‘setting the stage’ for the antigen

  2013cited by this paper
• Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.

  2013cited by this paper
• Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells

  2013cited by this paper
• Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice.

  2013cited by this paper
• Licensing Adaptive Immunity by NOD-Like Receptors

  2013cited by this paper
• Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data

  2013cited by this paper
• Serum Cytokine Profiles Associated with Specific Adjuvants Used in a DNA Prime-Protein Boost Vaccination Strategy

  2013cited by this paper
• First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children

  2013cited by this paper
• Matrix M Adjuvant Technology

  2013cited by this paper
• Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines

  2013cited by this paper
• GBP5 Promotes NLRP3 Inflammasome Assembly and Immunity in Mammals

  2012cited by this paper
• Synthesis and preclinical evaluation of QS-21 variants leading to simplified vaccine adjuvants and mechanistic probes.

  2012cited by this paper
• The NLRP12 inflammasome recognizes Yersinia pestis.

  2012cited by this paper
• A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

  2012cited by this paper
• ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases.

  2012cited by this paper
• ISCOM technology-based Matrix M™ adjuvant: success in future vaccines relies on formulation

  2011cited by this paper
• Enhancing Immunogenicity of Cancer Vaccines: QS-21 as an Immune Adjuvant.

  2011cited by this paper
• First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

  2011cited by this paper
• The inflammasome NLRs in immunity, inflammation, and associated diseases.

  2011cited by this paper
• RIP3 mediates the embryonic lethality of caspase-8-deficient mice

  2011cited by this paper
• Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems

  2011cited by this paper
• ISCOMATRIX Adjuvant Combines Immune Activation with Antigen Delivery to Dendritic Cells In Vivo Leading to Effective Cross-Priming of CD8+ T Cells

  2011influential reference
• Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer

  2011cited by this paper
• Regulation of adaptive immunity by the NLRP3 inflammasome.

  2011cited by this paper
• Regulation of the antimicrobial response by NLR proteins.

  2011cited by this paper
• Immunization with N-propionyl polysialic acid–KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci

  2011cited by this paper
• ISCOMATRIX™ vaccines: Safety in human clinical studies

  2010cited by this paper
• NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

  2010cited by this paper
• Regulation of Adaptive Immunity by the Innate Immune System

  2010influential reference
• The controversial relationship between NLRP3, alum, danger signals and the next‐generation adjuvants

  2010cited by this paper
• The controversial relationship between NLRP3, alum, danger signals and the next-generation adjuvants

  2010cited by this paper
• NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?

  2010cited by this paper
• NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease

  2010cited by this paper
• Mechanism of action of clinically approved adjuvants.

  2009cited by this paper
• ISCOMs and ISCOMATRIX.

  2009influential reference
• Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression1

  2009cited by this paper
• AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity1

  2009cited by this paper
• Alum Induces Innate Immune Responses through Macrophage and Mast Cell Sensors, But These Sensors Are Not Required for Alum to Act As an Adjuvant for Specific Immunity1

  2009cited by this paper
• Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome

  2009cited by this paper
• Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica

  2008cited by this paper
• Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

  2008cited by this paper
• The safety and tolerability of an HIV-1 DNA prime-protein boost vaccine (DP6-001) in healthy adult volunteers.

  2008cited by this paper
• The NALP3 inflammasome is involved in the innate immune response to amyloid-β

  2008cited by this paper
• Cutting Edge: Alum Adjuvant Stimulates Inflammatory Dendritic Cells through Activation of the NALP3 Inflammasome

  2008cited by this paper
• Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization

  2008influential reference
• Cutting Edge: Inflammasome Activation by Alum and Alum’s Adjuvant Effect Are Mediated by NLRP31

  2008influential reference
• Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.

  2008cited by this paper
• The Nlrp3 inflammasome is critical for aluminium hydroxide‐mediated IL‐1β secretion but dispensable for adjuvant activity

  2008cited by this paper
• GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives

  2007cited by this paper
• Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis.

  2006cited by this paper
• Gout-associated uric acid crystals activate the NALP3 inflammasome

  2006cited by this paper
• Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response

  2006cited by this paper
• Saponin adjuvants

  2005cited by this paper
• TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848).

  2005cited by this paper
• Synthetic peptides representing sequences within gp41 of HIV as immunogens for murine T- and B-cell responses

  2005cited by this paper
• Kinase RIP3 Is Dispensable for Normal NF-κBs, Signaling by the B-Cell and T-Cell Receptors, Tumor Necrosis Factor Receptor 1, and Toll-Like Receptors 2 and 4

  2004cited by this paper
• Current vaccine adjuvants: an overview of a diverse class.

  2004cited by this paper
• Of Mice . . .

  2004cited by this paper
• Role of Innate Immune Factors in the Adjuvant Activity of Monophosphoryl Lipid A

  2003influential reference
• QS-21 structure/function studies: effect of acylation on adjuvant activity.

  2002cited by this paper
• Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21.

  2002cited by this paper
• QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans.

  2001cited by this paper
• Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines.

  1999cited by this paper
• Saponins as vaccine adjuvants.

  1996cited by this paper
• Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function.

  1995influential reference
• Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex.

  1991cited by this paper
• Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses

  1984cited by this paper
• Action of Saponin on Biological Cell Membranes

  1962cited by this paper
• Action of saponin on biological cell membranes.

  1962cited by this paper
• Serveur Académique Lausannois SERVAL serval.unil.ch

  year unknowncited by this paper

• AddaVax, AddaS03, and Alum Effectively Enhance Cross-Reactive and Cross-Neutralizing Antibody Responses Against SARS-CoV-2 Induced by the Inactivated NDV-HXP-S Vaccine in Mice.

  2026cites this paper
• Aluminum adjuvants differentially induce IL-1β release in vitro yet share NLRP3 inflammasome-independent adjuvant effects in vivo

  2026cites this paper
• Transient skin stretching stimulates immune surveillance and promotes vaccine delivery via hair follicles.

  2025cites this paper
• QS-21: Structural insights, immunological mechanisms, and prospects for rational design of safer vaccine adjuvants.

  2025cites this paper
• Skin manifestations of SARS-CoV-2 infection and its vaccination.

  2025cites this paper
• The role of cell death pathways in respiratory viral infection and vaccination: two sides of the same coin

  2025cites this paper
• Leaf Saponins of Quillaja brasiliensis as Powerful Vaccine Adjuvants

  2025cites this paper
• A QS21+ CpG-Adjuvanted Rabies Virus G Subunit Vaccine Elicits Superior Humoral and Moderate Cellular Immunity

  2025cites this paper
• Matrix-M adjuvant triggers inflammasome activation and enables antigen cross-presentation through induction of lysosomal membrane permeabilization

  2025influential citation
• Comparative Cytokine and Histology Studies on HPV and Other Viral Vaccinations: No Pathogenicity of HPV Vaccine Adjuvants

  2025cites this paper
• Ex vivo model of functioning human lymph node reveals role for innate lymphocytes and stroma in response to vaccine adjuvant

  2025cites this paper
• The success of toll-like receptor 4 based vaccine adjuvants.

  2025cites this paper
• Nano/Micro-Enabled Modification and Innovation of Conventional Adjuvants for Next-Generation Vaccines

  2025cites this paper
• Matrix-M® adjuvant triggers inflammasome activation and enables antigen cross-presentation through induction of lysosomal membrane permeabilization

  2025influential citation
• Cellular and Molecular Mechanisms of Innate Memory Responses.

  2025cites this paper
• A safe saponin-based nano-strategy for manganese-mediated STING activation.

  2025cites this paper
• Advancements in saponin-based vaccine adjuvants

  2025cites this paper
• A Blend of natural phytobiotics enhances growth performance, feed efficiency, and the immuno-health status of fingerlings of Nile tilapia (Oreochromis niloticus)

  2025cites this paper
• Linking vaccine adjuvant mechanisms of action to function.

  2025cites this paper
• Glioblastoma Immunotherapy Adjuvants for Glial Cell Polarization Regulation

  2025cites this paper
• Protonated Phenanthroline Catalyzed Stereoselective Glycosylation: Synthesis and Evaluation of Saponin Adjuvant Lablaboside F and Variants Leading to Simplified Vaccine Adjuvants

  2025cites this paper
• Anti-inflammatory and hemocompatibility of saponin fractions from wild-growing rupturewort (Herniaria L.) species: In vitro study and phytochemical analysis.

  2025cites this paper
• From bark to bench: innovations in QS-21 adjuvant characterization and manufacturing

  2025cites this paper
• An Integrated Modular Vaccination System for Spatiotemporally Separated Perioperative Cancer Immunotherapy

  2025cites this paper
• Two Recombinant Cytomegalovirus Antigens Formulated with the SPA14 Adjuvant System: Impact of Temperature, pH and Excipients on the Stability of each Antigen and Adjuvant Component.

  2025cites this paper
• Methods of saponin purification from Quillaja sp. for vaccine adjuvant production

  2025cites this paper
• Effect of Dietary Natural Phytobiotics Mixture on Growth, Body Composition, Immune, and Antioxidant-Related Gene Expression of Nile Tilapia (Oreochromis niloticus) Fries

  2025cites this paper
• HIV vaccine candidate ΔV1gp120 formulated in ALFQA adjuvant augments mucosal immunity in female macaques

  2025cites this paper
• Modulation of antigen delivery and lymph node activation in non-human primates by saponin adjuvant SMNP

  2024cites this paper
• Modulation of antigen delivery and lymph node activation in nonhuman primates by saponin adjuvant saponin/monophosphoryl lipid A nanoparticle

  2024cites this paper
• Innate immune cell activation by adjuvant AS01 in human lymph node explants is age independent

  2024cites this paper
• Identification of CDK4/6 Inhibitors as Small Molecule NLRP3 Inflammasome Activators that Facilitate IL-1β Secretion and T Cell Adjuvanticity.

  2024cites this paper
• Immunological Activity of Vaccine Systems Containing Liposomal Nanocarriers against Protozoan-Induced Diseases: A Systematic Review.

  2024cites this paper
• Development of semisynthetic saponin immunostimulants

  2024cites this paper
• A broadly applicable protein-polymer adjuvant system for antiviral vaccines

  2024cites this paper
• The zebrafish as a potential model for vaccine and adjuvant development

  2024cites this paper
• Molecular regulation of NLRP3 inflammasome activation during parasitic infection

  2024cites this paper
• The predominant Quillaja Saponaria fraction, QS-18, is safe and effective when formulated in a liposomal murine cancer peptide vaccine.

  2024cites this paper
• Vaccine adjuvants for infectious disease in the clinic

  2024cites this paper
• Chemical and biological characterization of vaccine adjuvant QS-21 produced via plant cell culture

  2024cites this paper
• Plant-derived galactolipids enhance specific antibody production and induce class-switch as vaccine adjuvant.

  2024cites this paper
• Saponin TQL1055 adjuvant-containing vaccine confers protection upon Mycobacterium tuberculosis challenge in mice

  2024cites this paper
• Emulsion and liposome-based adjuvanted R21 vaccine formulations mediate protection against malaria through distinct immune mechanisms

  2023cites this paper
• Importance of adjuvant selection in tuberculosis vaccine development: Exploring basic mechanisms and clinical implications

  2023cites this paper
• NLRP3 and cancer: Pathogenesis and therapeutic opportunities.

  2023cites this paper
• Targeting innate immune pathways for cancer immunotherapy.

  2023cites this paper
• Evolution of Vaccines Formulation to Tackle the Challenge of Anti-Microbial Resistant Pathogens

  2023cites this paper
• Protective effects of Zishen Huoxue recipe against neuronal injury in the neurovascular unit of rats with vascular dementia by interfering with inflammatory cascade-induced pyroptosis.

  2023cites this paper
• HECT, UBA and WWE domain containing 1 represses cholesterol efflux during CD4+ T cell activation in Sjögren’s syndrome

  2023cites this paper
• 3-Hydroxybutyrate-containing triterpenoid saponins from Brachyscome angustifolia and their immunogenic activity.

  2023cites this paper
• Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides

  2023cites this paper
• Protective Efficacy and Immunogenicity of Rv0351/Rv3628 Subunit Vaccine Formulated in Different Adjuvants Against Mycobacterium tuberculosis Infection

  2023cites this paper
• The Matrix-M™ adjuvant: A critical component of vaccines for the 21st century

  2023influential citation
• Malaria therapeutics: are we close enough?

  2023cites this paper
• Shatavarin-IV saponin adjuvant elicits IgG and IgG2b responses against Staphylococcus aureus bacterin in a murine model

  2023cites this paper
• Non-canonical inflammasome activation mediates the adjuvanticity of nanoparticles

  2023cites this paper
• Potentials of saponins-based adjuvants for nasal vaccines

  2023influential citation
• A-910823, a squalene-based emulsion adjuvant, induces T follicular helper cells and humoral immune responses via α-tocopherol component

  2023cites this paper
• Preclinical developments in the delivery of protein antigens for vaccination

  2023cites this paper
• Similarities and differences of chemical compositions and physical and functional properties of adjuvant system 01 and army liposome formulation with QS21

  2023cites this paper
• Saponins: Research Progress and Their Potential Role in the Post-COVID-19 Pandemic Era

  2023cites this paper
• Exploration of the immuno-adjuvant effect and mechanism of Anemoside B4 through network pharmacology and experiment verification.

  2023cites this paper
• Army liposome formulation containing QS-21 render human monocyte-derived macrophages less permissive to HIV-1 infection by upregulating APOBEC3A

  2022cites this paper
• Structure Elucidation of Triterpenoid Saponins Found in an Immunoadjuvant Preparation of Quillaja brasiliensis Using Mass Spectrometry and 1H and 13C NMR Spectroscopy

  2022cites this paper
• CYP51-mediated cholesterol biosynthesis is required for the proliferation of CD4+ T cells in Sjogren’s syndrome

  2022cites this paper
• Inflammasome and Inflammatory Programmed Cell Death in Chromoblastomycosis

  2022cites this paper
• A specific Leishmania infantum polyepitope vaccine triggers Th1-type immune response and protects against experimental visceral leishmaniasis.

  2022cites this paper
• Adjuvant Effects of a New Saponin Analog VSA-1 on Enhancing Homologous and Heterosubtypic Protection by Influenza Virus Vaccination

  2022cites this paper
• Multimerization of Ebola GPΔmucin on protein nanoparticle vaccines has minimal effect on elicitation of neutralizing antibodies

  2022cites this paper
• Immunostimulatory Polymers as Adjuvants, Immunotherapies, and Delivery Systems

  2022cites this paper
• Vaccine adjuvants to engage the cross-presentation pathway

  2022cites this paper
• Vaccine-induced time- and age-dependent mucosal immunity to gastrointestinal parasite infection

  2022cites this paper
• Resolving adjuvant mode of action to enhance vaccine efficacy.

  2022cites this paper
• Designing Adjuvant Formulations to Promote Immunogenicity and Protective Efficacy of Leptospira Immunoglobulin-Like Protein A Subunit Vaccine

  2022cites this paper
• Development of (Inhalable) Dry Powder Formulations of AS01B-Containing Vaccines Using Thin-Film Freeze-Drying.

  2022cites this paper
• Development of Dry Powder Formulations of AS01B containing vaccines using Thin-Film Freeze-Drying

  2022cites this paper
• Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases

  2022cites this paper
• Liposomes as Adjuvants and Vaccine Delivery Systems

  2022cites this paper
• An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives

  2022cites this paper
• Adjuvant effect of two polysaccharides from the petals of Crocus sativus and its mechanisms.

  2022cites this paper
• Caspase-1-Dependent Pyroptosis Mediates Adjuvant Activity of Platycodin D as an Adjuvant for Intramuscular Vaccines

  2022cites this paper
• Inflammasome Contribution to the Activation of Th1, Th2, and Th17 Immune Responses

  2022cites this paper
• Delivery strategies for cancer vaccines and immunoadjuvants

  2022cites this paper
• Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in Human Cells and In Vivo Activity

  2021cites this paper
• Promising Adjuvants and Platforms for Influenza Vaccine Development

  2021cites this paper
• CCR2- and Flt3-Dependent Inflammatory Conventional Type 2 Dendritic Cells Are Necessary for the Induction of Adaptive Immunity by the Human Vaccine Adjuvant System AS01

  2021cites this paper
• A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice

  2021cites this paper
• Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action

  2021cites this paper
• The Immunogenicity of Capsid-Like Particle Vaccines in Combination with Different Adjuvants Using Different Routes of Administration

  2021influential citation
• Targeting Innate Immunity in Cancer Therapy

  2021cites this paper
• Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments

  2021cites this paper
• Natural and Synthetic Saponins as Vaccine Adjuvants

  2021cites this paper
• A review of combination adjuvants for malaria vaccines: a promising approach for vaccine development.

  2021cites this paper
• Emerging concepts in the science of vaccine adjuvants

  2021cites this paper
• A chimeric vaccine combined with adjuvant system induces immunogenicity and protection against visceral leishmaniasis in BALB/c mice.

  2021cites this paper
• The right time and place: time- and age-dependent vaccine-enhanced mucosal immunity to parasite infection

  2021cites this paper
• Quillaja brasiliensis (A. St.-Hil. & Tul.) Mart.

  2021cites this paper
• NLRP3 inflammasomes that induce antitumor immunity.

  2021cites this paper
• Immunopotentiating and Delivery Systems for HCV Vaccines

  2021cites this paper
• The Phagosome–Lysosome Fusion Is the Target of a Purified Quillaja saponin Extract (PQSE) in Reducing Infection of Fish Macrophages by the Bacterial Pathogen Piscirickettsia salmonis

  2021cites this paper